SCHEMBL388472

SCHEMBL388472

CONCCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.58
TAAR1 Q96RJ0 1/20 0.58
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
KDM1A O60341 1/20 0.52
ALDH1A1 P00352 1/20 0.52
LMNA P02545 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
HTR1A P08908 1/20 0.52
ADRA2A P08913 1/20 0.52
CYP2C8 P10632 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
IDO1 P14902 1/20 0.52
TSHR P16473 1/20 0.52
NFKB1 P19838 1/20 0.52
MAOA P21397 1/20 0.52
PTGS1 P23219 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL28805506 0.98 ATM (0.56) ATMTAAR1NPC1RAB9ASMN1; SMN2
SCHEMBL31438227 0.87 SIGMAR1 (0.59) ATMTAAR1CYP2D6CYP2C9CYP2C19
SCHEMBL1258404 0.78 ATM (0.54) ATMTAAR1NPC1RAB9ASMN1; SMN2
SCHEMBL2583748 0.78 TMEM97 (0.61) TAAR1ALDH1A1LMNACYP3A4HTR1A
SCHEMBL28451160 0.78 ALDH1A1 (0.45) NPC1RAB9ASMN1; SMN2ALDH1A1LMNA
SCHEMBL6077274 0.78 TAAR1 (0.61) TAAR1ALDH1A1LMNAAOC3L3MBTL1
SCHEMBL28740936 0.77 SMN1; SMN2 (0.58) ATMTAAR1NPC1RAB9ASMN1; SMN2
SCHEMBL4770218 0.77 LMNA (0.52) ATMTAAR1NPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL11137669 0.77 TMEM97 (0.59) TAAR1ALDH1A1LMNACYP3A4HTR1A
Iodide SCHEMBL21800796 0.77 ATM (0.52) ATMTAAR1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114420852-B Preparation method of pure-phase RP perovskite film 河北工业大学 2025-05-27 CN claimed
CN-114824092-B Solar cell based on quasi-two-dimensional perovskite and preparation method thereof 北京炎和科技有限公司 2025-04-18 CN claimed
CN-116554862-A Zinc-based metal halide room-temperature phosphorescent material, and preparation method and application thereof 南京邮电大学 2023-08-08 CN claimed
CN-116367565-A Quasi two-dimensional perovskite nanocrystalline modified three-dimensional perovskite solar cell 河北工业大学 2023-06-30 CN claimed
CN-114824092-A Solar cell based on quasi two-dimensional-two-dimensional perovskite and preparation method thereof 河北工业大学 2022-07-29 CN claimed
CN-114420852-A Preparation method of pure-phase RP perovskite film 河北工业大学 2022-04-29 CN claimed
WO-2021181360-A1 NOVEL SALTS OF QUINOLONE COMPOUNDS CADILA HEALTHCARE LIMITED (IN) 2021-09-16 WO claimed
CN-110396115-A The application of the fire retardant of six (4- methoxyphenethylamine base) rings, three phosphonitrile and preparation method UNIV WEIFANG MEDICAL 2019-11-01 CN claimed
CN-106632368-B A kind of preparation method of irinotecan hydrochloride 上海金和生物制药有限公司 2019-03-08 CN claimed
CN-108899155-A A kind of preparation method of rare earth base semiconductor magnetic material 吴江市聚盈电子材料科技有限公司 2018-11-27 CN claimed
CN-103709161-B One-dimensional organic semiconductor nanowire with fluorescence and photoconduction dual response for organic amine gas as well as preparation method and application of nanowire CHINESE ACAD INST CHEMISTRY 2015-05-20 CN claimed
CN-104292751-A Flame-retardant epoxy resin composite material and preparation method thereof SUZHOU CHANGSHENG ELECTROMECHANICAL CO LTD 2015-01-21 CN claimed
EP-1487795-B1 SYNTHESIS OF ENANTIOMERICALLY PURE AMINO-SUBSTITUTED FUSED BICYCLIC RINGS ANORMED INC (CA) 2010-11-03 EP claimed
US-7135570-B2 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings ANORMED INC. (CA) 2006-11-14 US claimed
US-20050080267-A1 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings ANORMED, INC. (CA) 2005-04-14 US claimed
EP-1487795-A4 SYNTHESIS OF ENANTIOMERICALLY PURE AMINO-SUBSTITUTED FUSED BICYCLIC RINGS ANORMED INC (CA) 2005-02-09 EP claimed
EP-1487795-A2 SYNTHESIS OF ENANTIOMERICALLY PURE AMINO-SUBSTITUTED FUSED BICYCLIC RINGS ANORMED INC. (CA) 2004-12-22 EP claimed
US-20030114679-A1 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings ANORMED CORPORATION (CA) 2003-06-19 US claimed
WO-2003022785-A2 SYNTHESIS OF ENANTIOMERICALLY PURE AMINO-SUBSTITUTED FUSED BICYCLIC RINGS ANORMED INC. (CA) 2003-03-20 WO claimed
EP-0167451-B1 A NEW PROCESS FOR PREPARING NOVEL N-(ACYLOXY-ALKOXY) CARBONYL DERIVATIVES USEFUL AS BIOREVERSIBLE PRODRUG MOIETIES FOR PRIMARY AND SECONDARY AMINE FUNCTIONS IN DRUGS MERCK & CO. INC. (US) 1990-10-03 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030114679-A1 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings CBR1, POR, CBR3 ATM 4481/4885TAAR1 533/4885NPC1 3716/4885
US-20050080267-A1 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings CBR1, POR, CBR3 ATM 4481/4885TAAR1 533/4885NPC1 3716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.